PhenoAgeAccel is associated with all-cause and cardiovascular mortality in patients with diabetes and prediabetes: A cohort study.

Junyu Xi, Zeyu Zhang, Baoluo Hou, Yuqi Wu, Yifei Zhang, Weijing Liu

Key Laboratory of Chinese Internal Medicine of Ministry of Education, Dongzhimen Hospital, Beijing University of Chinese Medicine, Ocean Terminal Road 5, Dongcheng District, Beijing 100700, China.Key Laboratory of Chinese Internal Medicine of Ministry of Education, Dongzhimen Hospital, Beijing University of Chinese Medicine, Ocean Terminal Road 5, Dongcheng District, Beijing 100700, China. · pubmed

Paper

Abstract

Phenotypic Age Acceleration (PhenoAgeAccel) is a measure of biological aging, with higher scores indicating faster aging. Few studies have explored its association with mortality in patients with diabetes or prediabetes. This study aimed to investigate the predictive value of PhenoAgeAccel for all-cause and cardiovascular mortality in these patients.

The following analysis is generated by AI and may contain errors. It is separate from the authors’ abstract and is not peer review.

Research summary

PhenoAgeAccel is a predictor of all-cause and cardiovascular mortality in patients with diabetes and prediabetes. The study addresses biological aging and its implications for mortality, which is pertinent to longevity research.

Author of this paper? Send a correction.